Olivier is based in the New York office and shares his activity between the US and Europe. His areas of medical expertise include oncology, vaccines, respiratory, inflammation/autoimmune, and the central nervous system.
Olivier joined Bionest in 2004 and moved to the New York office in 2008 to develop US operations. He collaborates with teams from large pharma, leading biotech companies, and private equity funds. His specific project experience includes portfolio/franchise strategy development and implementation, support to drug development decision-making, life-cycle management strategy, corporate development strategy, market segmentation, and product positioning.
His skills lie in working with cross-functional franchise or product teams in order to foster alignment on decision-making related to development or commercial challenges. Olivier collaborates with his clients to identify compelling competitive differentiation, in order to maximize value proposition for key customers.
Olivier earned an MS in Management from EM-Lyon Business School and an MS in Molecular Biology from Polytech Clermont-Ferrand.
Listen to the interview (published November 2017) https://mendelspod.com/podcasts/immuno-oncology-2017-looking-back-lookin...